Product Description

LYSIGIN is a lysed culture of highly antigenic polyvalent somatic antigen containing phage types I, II, III, IV and miscellaneous groups of Staph aureus. LYSIGIN is recommended for the vaccination of healthy, susceptible cattle as an aid in the prevention of mastitis caused by Staphylococcus aureus.

Features & Benefits

  • Contains five different phage types of Staph aureus.
  • Includes capsular serotypes 5, 8, 336.
  • Reduces chronicity of infection when a vaccination program starts at an early age.
  • Allows cows opportunity to reach their genetic potential for milk production.

Dosage Information
  • Using aseptic technique, inject 5 mL intramuscularly.
  • Repeat in 14 days. Follow with a single 5 mL booster dose each 5 to 6 months. Start vaccinating all heifers at 6 months of age.

Safety information

  • Store out of direct sunlight at a temperature between 35-45°F (2-7°C). Avoid freezing. Shake well before using. Use entire contents when first opened.
  • Do not vaccinate within 21 days before slaughter.
  • Anaphylactoid reactions may occur. Antidote: Epinephrine

Efficacy of LYSIGIN in reducing the new infection rate and somatic cell count in a commercial dairy.

Product Resources

Contact Information

  • Boehringer Ingelheim Animal Health USA Inc.

    Cattle Division

    3239 Satellite Blvd NW,
    Duluth, GA 64506

    • Phone 866-638-2226
    • Fax 816-326-9167
    • e-mail